POTUS Donald Trump jumps to take credit as Moderna announce 94.5% COVID vaccine efficacy

Crying foul over recently concluded US Presidential Elections, POTUS Donald Trump on Monday, jumped to take credit as Moderna anunced that its COVID-19 vaccine candidate has shown nearly 95% efficacy. In a tweet directed at his critiques, Trump asked m to take te of great discoveries which will end 'China Plague' and highlighted that it all happened under his watch. This comes after Pfizer h anunced earlier that its COVID vaccine candidate showed over 90% efficacy, of which Trump h claimed credit as well. 

Following Donald Trump, his deputy Mike Pence too credited ir ministration for Moderna's success. Pence highlighted that Moderna h partnered with President Trump and National Institutes of Health on January 13, 2020, for development of vaccine. Referring to Moderna's anuncement, Pence tweeted, "Operation Warp Speed is a success because of strong leership of this President!"

RE | Moderna's COVID Vaccine Reports 94.5% Efficacy, To Seek US FDA's Emergency Authorization

Trump and Pence's comments come as duo continues to claim irregularities in 2020 US Presidential Election, in which, Democrats led by Joe Biden have emerged victorious, as per AP. Trump, who has 232 electoral college votes, has challenged election results in various states including Pennsylvania, Neva, Michigan, Georgia and Arizona. He h demanded a recount in Wisconsin. He has launched a slew of lawsuits in key states but has t provided any evidence to back his claims of fraud. All his lawsuits have so far been unsuccessful. As Trump has refused to concede election, transition team of Biden and vice-president-elect Kamala Harris says that Trump ministration is t cooperating with m in transition. 

RE | WHO Chief Warns Vaccine Won't Be Eugh To Stop COVID, Says 'it'll Complement Or Tools'

Moderna anunces 94.5% Efficacy of COVID vaccine

Anuncing results of its phase three trials, Moderna on Monday reported that its COVID-19 vaccine candidate has proven to be 94.5% effective. biotechlogy company has informed that it intends to submit COVID-19 vaccine candidate for an Emergency Use Authorization (EUA) with United States' Food & Drug ministration (FDA). analysis released by Moderna which has reported 94.5% efficacy of COVID-19 vaccine was based on results of more than 30,000 participants in US. 

RE | Trump's 'I Won Election' Tweet Gives People Monday Motivation, Netizens Say 'genius'

analysis report of Moderna vaccine revealed that 'preliminary analysis suggests a broly consistent safety and efficacy profile across all evaluated subgroups. Moderna's Phase 3 trials are randomized and including providing vaccine shots at 100 µg dose level in 30,000 participants in U.S., s 18 and older. 

On vember 10, Pfizer Inc anunced that its mRNA-based COVID-19 vaccine candidate which was found 90 per cent effective in first interim analysis from Phase III study, will be distributed in December across US, Pfizer confirmed in a press release. Developed with German partner BioNTech SE, Pfizer’s COVID-19 vaccine was declared effective against SARS-CoV-2 by independent Data Monitoring Committee (DMC) in an analysis conducted on vember 8, 2020. 

RE | Irked Trump Lambasts Media For 'assuming' Biden Winner, Says Election Was 'attacked'